These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32106799)

  • 1. Papain Mediated Synthesized Gold Nanoparticles Encore the Potency of Bioconjugated Flutamide.
    Xu X; Man L
    Curr Pharm Biotechnol; 2021; 22(4):557-568. PubMed ID: 32106799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gold nanoconjugates reinforce the potency of conjugated cisplatin and doxorubicin.
    Iram S; Zahera M; Khan S; Khan I; Syed A; Ansary AA; Ameen F; Shair OHM; Khan MS
    Colloids Surf B Biointerfaces; 2017 Dec; 160():254-264. PubMed ID: 28942160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micellar delivery of flutamide via milk protein nanovehicles enhances its anti-tumor efficacy in androgen-dependent prostate cancer rat model.
    Elzoghby AO; Helmy MW; Samy WM; Elgindy NA
    Pharm Res; 2013 Oct; 30(10):2654-63. PubMed ID: 23739989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced delivery system of flutamide loaded chitosan-dextran sulphate nanoparticles for prostate cancer.
    Anitha A; Uthaman S; Nair SV; Jayakumar R; Lakshmanan VK
    J Biomed Nanotechnol; 2013 Mar; 9(3):335-47. PubMed ID: 23620988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elaboration of polymersomes versus conventional liposomes for improving oral bioavailability of the anticancer flutamide.
    Youssef SF; Elnaggar YS; Abdallah OY
    Nanomedicine (Lond); 2018 Dec; 13(23):3025-3036. PubMed ID: 30507344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ionically-crosslinked milk protein nanoparticles as flutamide carriers for effective anticancer activity in prostate cancer-bearing rats.
    Elzoghby AO; Saad NI; Helmy MW; Samy WM; Elgindy NA
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):444-51. PubMed ID: 23872177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Casein-based micelles: a novel vector for delivery of the poorly soluble anticancer drug, flutamide?
    Elgindy NA; Samy WA; Elzoghby AO
    Ther Deliv; 2014 Jan; 5(1):7-9. PubMed ID: 24341810
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel route synthesis of porous and solid gold nanoparticles for investigating their comparative performance as contrast agent in computed tomography scan and effect on liver and kidney function.
    Aziz F; Ihsan A; Nazir A; Ahmad I; Bajwa SZ; Rehman A; Diallo A; Khan WS
    Int J Nanomedicine; 2017; 12():1555-1563. PubMed ID: 28280325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Poly (vinyl alcohol) Coated Flutamide Nanoparticulates and their Efficacy on Prostate Cancer Cells.
    Suseelan SR; Sreenivasan SK; Nair SV; Lakshmanan VK
    Curr Drug Deliv; 2017; 14(5):641-649. PubMed ID: 27758693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of resveratrol-conjugated gold nanoparticles: interrelationship of increased resveratrol corona on anti-tumor efficacy against breast, pancreatic and prostate cancers.
    Thipe VC; Panjtan Amiri K; Bloebaum P; Raphael Karikachery A; Khoobchandani M; Katti KK; Jurisson SS; Katti KV
    Int J Nanomedicine; 2019; 14():4413-4428. PubMed ID: 31417252
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative study of the clinical efficacy of two dosing regimens of flutamide.
    Thrasher JB; Deeths J; Bennett C; Iyer P; Dineen MK; Zhai S; Figg WD; McLeod DG
    Mol Urol; 2000; 4(3):259-63;discussion 265. PubMed ID: 11062382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folate-Targeted Polyacrylamide/Punicic Acid Nanomicelles for Flutamide Delivery in Prostate Cancer: Characterization, In Vitro Biological Evaluation, and its DFT Study.
    Mirsafaei R; Varshosaz J; Mirsattari SN
    Recent Pat Nanotechnol; 2020; 14(4):360-374. PubMed ID: 32400341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D2B-Functionalized Gold Nanoparticles: Promising Vehicles for Targeted Drug Delivery to Prostate Cancer.
    Sarkis M; Minassian G; Mitri N; Rahme K; Fracasso G; El Hage R; Ghanem E
    ACS Appl Bio Mater; 2023 Feb; 6(2):819-827. PubMed ID: 36755401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel of nano delivery system for Linalool loaded on gold nanoparticles conjugated with CALNN peptide for application in drug uptake and induction of cell death on breast cancer cell line.
    Jabir MS; Taha AA; Sahib UI; Taqi ZJ; Al-Shammari AM; Salman AS
    Mater Sci Eng C Mater Biol Appl; 2019 Jan; 94():949-964. PubMed ID: 30423784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
    Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
    Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
    [No Abstract]   [Full Text] [Related]  

  • 16. Targeted non AR mediated smart delivery of abiraterone to the prostate cancer.
    Baker A; Khalid M; Uddin I; Khan MS
    PLoS One; 2022; 17(8):e0272396. PubMed ID: 36018864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological synergy of greener gold nanoparticles by using Coleus aromaticus leaf extract.
    Boomi P; Ganesan RM; Poorani G; Gurumallesh Prabu H; Ravikumar S; Jeyakanthan J
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():202-210. PubMed ID: 30889692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiandrogen in prostate cancer].
    Maeda O; Usami M
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():188-92. PubMed ID: 12599569
    [No Abstract]   [Full Text] [Related]  

  • 19. Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol.
    Chang A; Yeap B; Davis T; Blum R; Hahn R; Khanna O; Fisher H; Rosenthal J; Witte R; Schinella R; Trump D
    J Clin Oncol; 1996 Aug; 14(8):2250-7. PubMed ID: 8708714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antiandrogen withdrawal syndrome. Experience in a large cohort of unselected patients with advanced prostate cancer.
    Small EJ; Srinivas S
    Cancer; 1995 Oct; 76(8):1428-34. PubMed ID: 8620419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.